News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
199 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21098)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (164)
2 (27)
3 (38)
4 (284)
5 (268)
6 (206)
7 (197)
8 (98)
9 (4)
10 (7)
11 (190)
12 (219)
13 (201)
14 (199)
15 (83)
16 (9)
17 (6)
18 (182)
19 (259)
20 (94)
21 (65)
22 (40)
23 (1)
24 (3)
25 (64)
26 (61)
27 (54)
28 (44)
29 (94)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
Genentech Announces New OCREVUS (Ocrelizumab) Data on Long-Term Disability Benefits in Primary Progressive Multiple Sclerosis and Initiation of Two Global Studies in Progressive MS
Genentech announced today that new OCREVUS® (ocrelizumab) data will be presented at the 4th Congress of the European Academy of Neurology.
June 14, 2018
·
16 min read
Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge
Avrum Spira, Global Head, Lung Cancer Initiative, Johnson & Johnson, and Melinda Richter, Global Head, Johnson & Johnson Innovation, JLABS, made the announcement at CES Asia in Shanghai, China.
June 14, 2018
·
2 min read
Biotech Bay
Mindstrong Health Announces $15M Series B Round Financing and Business Update
Round includes new investor Bezos Expeditions and Decheng Capital with Series A investors Optum Ventures, ARCH Venture Partners and Foresite Capital
June 14, 2018
·
3 min read
Business
Cheetah Medical’s French Distributor SEBAC SA to Supply Starling SV Monitoring Systems to Paris’ Public Hospital System
The four-year deal calls for the Starling SV Hemodynamic Monitoring System to be installed in more than 40 hospitals around Greater Paris.
June 14, 2018
·
3 min read
Drug Development
Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy
Phase 1/2 clinical trial in patients with advanced solid tumors that have progressed on anti-PD-1/PD-L1 therapy to evaluate APX005M in combination with cabiralizumab and Opdivo
June 14, 2018
·
3 min read
Policy
OTC Markets Group Welcomes The Green Organic Dutchman Holdings Ltd. to OTCQX
OTC Markets Group Inc. announced The Green Organic Dutchman Holdings Ltd. has qualified to trade on the OTCQX® Best Market.
June 14, 2018
·
3 min read
BioForest
CTI BioPharma to Present at the JMP Securities 2018 Life Sciences Conference
CTI BioPharma Corp. announced that management will present at the JMP Securities 2018 Life Sciences Conference in New York
June 14, 2018
·
1 min read
Business
The Committee of prominent health researchers and Nobel laureates renames the Prix Galien Pro Bono Humanum Award to recognize the global health leadership of Dr. Roy Vagelos
The Prix Galien USA Committee announced today that the Prix Galien Pro Bono Humanum Award for individual service to improve the state of human health will be renamed in honor of Dr. P. Roy Vagelos, Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board, Regeneron Pharmaceuticals.
June 14, 2018
·
5 min read
Business
Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference
Avelas Biosciences, Inc. announced that Carmine N. Stengone, President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference
June 14, 2018
·
1 min read
Business
Future Farm Begins Build-out Process in Massachusetts and Completes Demolition Phase in Rhode Island
The building is located in an M-1 zone, which legally permits the cultivation of cannabis by right
June 14, 2018
·
4 min read
Previous
5 of 20
Next